Text size

Taro Pharmaceutical Industries last Thursday reported a 15% decline in sales and a 20% drop in gross profits, but its stock still rose by 6% on the two subsequent trading days and by another 1.1% on Tuesday. There is an explanation for the stock’s bizarre behavior, but what is harder to comprehend is that based on its current share price, the company is now worth $6.3 billion. After all,...